Expression of Gene Control Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are the eukaryotic DNA control elements?

A

TATA box
Promoter proximal elements
Enhancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the TATA box

A

25-35bp upstream of transcription start site
determines site of transcription initiation
Directs binding protein of RNA pol I (where general transcription factors bind)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe promoter proximal element

A

within 200bp upstream of transcription start site
~20bp long
regulates transcription -> bound by cell specific factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe enhancers

A

Multiple control elements, 8-20 bp long each=> up to 100-200 bp long total

200 tens of kbp upstream or downstream from promotor, or last exon of gene, also within intron

Regulate transcription in cell specific way

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe thalassemia β

A

inherited anemia caused by insufficient production of β-globin protein by erythroid cells

Caused by many mutations, including at promoter-> reduces amound of β-globin mRNA -> decreases protein production (clinically mild)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe thalassemia γδβ

A

caused by deletion of locus control region (LCR) of β-globin gene cluster
Hemophilia B Leyden

X linked clotting disorder
1% of normal factor IX until puberty in males (result of mutation in promoter => prevents binding of transcriptional activators )

After puberty up to 60% of normal factor IX due to androgen receptor activation that has overlapping binding sites at promoter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe fragile X syndrome

A

Mental retardation, dimorphic facial features, macroorchidism (abn large testes) in 1/1,500 males

CGG repeat at 5’ region of FMR I gene-> methylation of cytosine residues in CpG-> transcriptional inactivation of FMR I gene

Normal = 6-50 repeats, Fragile x = > 200 repeat -> increased transcriptional silencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the role of transcriptional activators and repressors?

A

They are proteins that are encoded by one gene but act on other genes (Trans) regulating (increasing or decreasing) transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 2 classes of sequence activators and repressors?

A

Sequence specific binding proteins

Cofactors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do sequence specific binding proteins work?

A

Binds promoter or enhancer in target genes to reg. transcription

Usually binds element 6-8bp long

Bind by inserting α Helices into major groove of DNA -> creates contact between amino acid side chains of protein and based of DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do cofactors work?

A

Do not bind DNA directly

bind sequence specific DNA binding proteins -> affect translation

Cause sequence specific DNA binding proteins to work more or less efficiently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the domains of sequence specific DNA binding proteins

A

They have 2 (modular)

DNA binding domain - reads DNA and binds with high specificity – highly conserved

Activation/ repressor domain - binds cofactors, on outside, bind general transcription factors, not highly conserved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe helix turn helix sequence specific DNA binding proteins

A
Homeodomain 
act on simillar genes 
Important for development
HOX family, Pit 1, MSX
60 aa domain
 2 alpha helicies -> motif
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe zinc finger sequence specific DNA binding proteins

A

tetrahedral organizaiton created by Zn residue

Bind nuclear receptors for Estrogen, androgen, retinoic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the basic helix loop helix sequence specific DNA binding proteins

A

zipper with looped region
myoD, myogenin, Myf5
homo and hetero dimers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the basic leucine zipper

A

dimerized through alpha-helical zipper domains
no loop
homo and heterodimerization
c-fos, c-jun

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe androgen insensitivity syndrome

A

decreased androgen response due to mutation in AR DNA binding domain or ligand binding domain <- mutation in binding domain or ligand binding domain (zinc finger)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe waardenburg syndrome type II

A

Mutation of MITF gene renders it nonfunctional -> this affects transcription of genes important in pigmentation and hearing

protein made but does not function -> cannot bind to DNA to activate Genes (basic helix loop helix)

19
Q

Describe Msx2 and craniosynostosis

A

Proline to histidine substitution-> causes tighter binding to DNA -> excessive expression of gene-> premature fusion of skull

20
Q

How is combinatorial control a mechanism for controlling gene expression?

A

Increases number of potential sequences where family or sequence specific transcription factors can bind -> new DNA binding specificity

Available to zinc finger, bZIP, bHLH

21
Q

How do transcriptional activators and repressors control transcription once they are bound to DNA?

A

by regulating assembly of initiation complexes

regulating rate of initiation of transcription

regulating changes in chromatin structure (ability of transcription factors to bind promoters)

22
Q

What are the 2 classes of chromatin remodeling factors? How do they work?

A

DNA dependent ATP-ases

  • SWI/SNFs
  • disrupt histone octamers and DNA

HATs and HDAC
-reversibly modify histones via acetylation

23
Q

What are HATs and HDACs and how does their activity influence transcription?

A

HATs: histone acetyltransferases

  • Acetylate n-terminal of histone
  • Neutralizes positively charged ends -> decrease DNA interaction?
  • Acetylation of lysine -> specific transcription factor binding -> pattern of Acetylation = code to recruit factors & influence binding
  • Co-activators

HDACs: Histone deacyetylases

  • Keep, return + charge -> interaction with – DNA?
  • Acetylation of lysine (pattern) = code for transcription factor binding
  • Co-repressors

Trans acting factors can work as activators or repressors by recruiting HATs or HDACs

24
Q

Give an example of a disease where histone acytlation has been altered, describe the defect

A

Rubinstein-Taybi Syndrome

  • Rare 1/125,000
  • Growth retardation, mental retardation, craniofacial dysmorphism, abnormally broad thumbs and great toes
  • Mutation of CREB binding protein (CBP) -> co-activator of many transcription factors
  • Transcription of MANY genes does not take place or is insufficient

Leukemia

  • Hematopoietic malignancy
  • Gain of function of fusion-proteins -> altered activity of regulators
25
Q

How do activators/repressors modulate transcription?

A

interact with general transcription factors/ Pol II proteins

Change initiation or elongation of transcript
Influence rate of initiation

26
Q

How do activators/repressors modulate transcriptional machinery?

A

Influence rate of assembly

27
Q

How do activators/repressors modulate chromatin?

A

change transcription factor’s ability to bind (accessibility)

28
Q

How are transcriptional regulation and specificity achieved?

A

regulation
-depends on DNA-protein and protein-protein interaction-> change DNA conformation or chromatin structure and initiation complex forms

specificity
-depends on binding of transcriptional activators or repressors to DNA control elements

29
Q

How does protein-DNA interaction contribute to transcriptional control?

A

control is combinatorial
- several thousand transcriptional activators/repressors can differentially change expression of genes in different cells in response to different stimuli

30
Q

What is Euchromatin?

A

Where genes reside in accessible form of chromatin

31
Q

What is heterochromatin?

A

Repressed because DNA is inaccessible

-on centromeres, telomeres and internal chromosome positions

32
Q

What is the difference between constitutive and facultative heterochromatin?

A

Constitutive - always inaccessible, contains satellite DNA
ex. centromeric DNA

Facultative - can be euchromatin, depends on cell type, developmental stage and enriched LINE sequences
ex. X-inactivation

33
Q

How are sequence specific DNA binding proteins regulated?

A

regulation of conformation of DNA binding protein changes due to ligand binding (i.e. zinc finger)

Regulation of entry of DNA binding proteins into nucleus (nuclear localization region- NLR)

Regulation of amount of transcription factor in cell ([concentration])

Regulation of DNA binding

Phosphorylation of DNA binding protein changes protein degradation, recruitment of co-activators and DNA binding

34
Q

How is the activity of nuclear hormone receptors controlled?

A

In nuclear receptors binding of hormones affect receptor and recruitment of co-activators/ repressors and translocation into nuclies
i.e estrogen receptor activation, glucocorticoid receptor activation

35
Q

How does Tamoxifen act in breast cancer therapy?

A

Normal: estrogen induces transcriptional activation through estrogen receptor (causes Dimerization of ER -> histone acetylation-> pol II recruitment -> CTD Phosphorylation -> ER/p160 release)

In pathology (ER + breast cancer): Tamoxifen binds ER, prevents recruitment of HATs -> no acetylation of histones -> no recruitment of pol II (may recruit depressors)

36
Q

How does NFkb pathway work? What drug changes its pathway, and how does it work?

A

Held in cytoplasm by binding to inhibitor (IkB) which masks nuclear localization signal

  • If Ikb phosphorylated -> degraded -> NFkB released and moves to nucleus
  • In nucleus NFkB turns on genes involved in inflammatory response

Asprin is anti-inflammatory in part b/c inhibits phosphorylation -> IkB not degraded and NFkB cannot enter nucleus to activate inflammatory genes

37
Q

How does NF-AT pathway work? What drug changes this pathway and how does it work?

A
  • Phosphorylated in cytoplasm, cannot enter nucleus
  • High intracellular Ca -> activates calcineurin’s phosphatase activity -> NF-AT dephosphorylated -> nuclear localization sequence exposed -> goes to nucleus
  • In nucleus NF-AT affects transcription of immune response genes & heart function

Immunosuppresants (cyclosporine and FK506) -> inhibit calcineurin => inhibit NF-AT

38
Q

Describe the β-Catenin pathway and how it can be changed

A

Typically phosphorylated by APC, GSK3 and Axin (due to absence of Wnt signaling)
-if Wnt signaling occurs -> β-Catenin no longer phosphorylated (targeted for ubiquitination) b/c APC and complexing proteins destabilized -> cytoplasm concentration increases

  • up [β-Catenin] -> some enters nucleus -> interacts with TCF family transcription factors -> promotes expresson of Wnt responsive genes

Positive feedback loop

39
Q

What type of cancer is APC mutation involved in?

A

Colon cancer

40
Q

How does p53 work normally?

A

Guardian of Genome
active in growth arrest, DNA repair, apoptosis

down regulated by MDM2 binding (masks activation domain targets for destruction by ubiquitin- proteosome pathway

present in >50% of cancers

41
Q

Describe ubiquitin and its function

A

ubiquitous (highly conserved)
yeast = human

Covalently linked to protein by ATP dependent pathways of E1, E2 & E3 enzymes

Once ubiquinated, proteins taken to 26s proteosome for degradation

42
Q

Describe how DNA binding activity of sequence specific DNA binding protein can be inhibited

A

Id proteins
Heterodimerize with helix loop helix domains
-prevent DNA binding through loss of basic domain

43
Q

Describe a protein modification that can alter activity of a sequence specific DNA binding protein

A

Phosphorylation affects activity of trans acting factors

  • CREB (Cyclic AMP response element binding protein) -> phosphorylated due to events triggered by ligand binding to guanine nucleotide binding protein coupled receptor
  • CREB in active until phosphorylated -> if phosphorylated recruits histone acytly transferase, CBP (with HAT activity -> RNa pol II) => => activation of gene

Rubinstein-Taybi Syndrome

  • Rare 1/125,000
  • Growth retardation, mental retardation, craniofacial dysmorphism, abnormally broad thumbs and great toes
  • Mutation of CREB binding protein (CBP) -> co-activator of many transcription factors
  • Transcription of MANY genes does not take place or is insufficient
44
Q

Beyond transcriptional regulation, how can gene expression be controlled?

A

control of mRNA export from nucleus

control of mRNA degradation

control of efficiency of translation

control of protein degradation